https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4...

  1. 16,291 Posts.
    lightbulb Created with Sketch. 6189
    https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4755-815d-99adf40ddc17

    upload_2022-1-5_12-53-55.png



    There have been a number of scenarios of Real World Evidence (RWE) that IMO support Mesoblast's decision to plan to run and additional COVID-19 ARDS Phase 3 trial using Remestemcel-L ... I thought we could use this thread to post them as we come across them ?  Use the thread or don't use it;  entirely up to you



    An exponential increase in case numbers like this - 1,044,970 new cases in one day and USA hospitalisations up by 41% in two weeks would IMO support SI's reasons for undertaking an additional COVID-19 ARDS Phase 3 trial in the USA using our Remestemcel-L treatment.


    https://www.nbcnews.com/news/us-new...-covid-cases-spread-omicron-variant-rcna10866

    U.S. reaches 1 million daily Covid cases in spread of omicron variant
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.67
Change
0.015(0.91%)
Mkt cap ! $2.133B
Open High Low Value Volume
$1.65 $1.67 $1.63 $3.655M 2.203M

Buyers (Bids)

No. Vol. Price($)
2 48000 $1.66
 

Sellers (Offers)

Price($) Vol. No.
$1.67 98565 7
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.